Hepatic Arterial Chemotherapy Infusion Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors for Advanced Hepatocellular Carcinoma with High Risk: A Propensity Score Matching Study

Medicine, Hepatobiliary System, Oncology,
Advanced Hepatocellular Carcinoma   Hepatic Arterial Infusion Chemotherapy   High Risk   Programmed Cell Death Protein-1 Inhibitors   Propensity Score Matching   Triple Therapy   Tyrosine Kinase Inhibitors  

Study on the Application of Hepatic Arterial Chemotherapy Combined with Targeted and Immunotherapy in Advanced Liver Cancer Background Liver cancer is the sixth most commonly diagnosed cancer globally and the third leading cause of cancer-related deaths. Most patients are diagnosed at an advanced stage, losing the opportunity for surgical resection...